{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T20:06:34Z","timestamp":1792267594249,"version":"4.4.0"},"reference-count":54,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T00:00:00Z","timestamp":1779148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T00:00:00Z","timestamp":1779148800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100002383","name":"King Saud University","doi-asserted-by":"crossref","award":["ORF-2026-748"],"award-info":[{"award-number":["ORF-2026-748"]}],"id":[{"id":"10.13039\/501100002383","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Metab Brain Dis"],"DOI":"10.1007\/s11011-026-01870-4","type":"journal-article","created":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T03:22:53Z","timestamp":1779160973000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Tirzepatide attenuates neurotoxicity by suppressing inflammation, apoptosis and restoring neurotrophin expression in an Alzheimer\u2019s disease-like rat model"],"prefix":"10.1007","volume":"41","author":[{"ORCID":"https:\/\/orcid.org\/0009-0002-3623-1137","authenticated-orcid":false,"given":"Mohamed S.M.","family":"Attia","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8282-3726","authenticated-orcid":false,"given":"Sheikh F.","family":"Ahmad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2038-8367","authenticated-orcid":false,"given":"Ahmed","family":"Nadeem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3556-5939","authenticated-orcid":false,"given":"Mushtaq A.","family":"Ansari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7424-0910","authenticated-orcid":false,"given":"Mohammed A.","family":"Al-Hamamah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7988-4421","authenticated-orcid":false,"given":"Gamaleldin I.","family":"Harisa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2008-6377","authenticated-orcid":false,"given":"Saleh A.","family":"Bakheet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3188-2272","authenticated-orcid":false,"given":"Talha Bin","family":"Emran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9038-8082","authenticated-orcid":false,"given":"Tanveer","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8560-8944","authenticated-orcid":false,"given":"Sabry M.","family":"Attia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,19]]},"reference":[{"key":"1870_CR1","doi-asserted-by":"publisher","first-page":"113072","DOI":"10.1016\/j.biopha.2022.113072","volume":"151","author":"F Abbas","year":"2022","unstructured":"Abbas F, Eladl MA, El-Sherbiny M, Abozied N, Nabil A, Mahmoud SM, Mokhtar HI, Zaitone SA, Ibrahim D (2022) Celastrol and thymoquinone alleviate aluminum chloride-induced neurotoxicity: Behavioral psychomotor performance, neurotransmitter level, oxidative-inflammatory markers, and BDNF expression in rat brain. Biomed Pharmacother 151:113072","journal-title":"Biomed Pharmacother"},{"key":"1870_CR2","doi-asserted-by":"publisher","first-page":"1092","DOI":"10.1177\/0960327118755256","volume":"37","author":"YS Abulfadl","year":"2018","unstructured":"Abulfadl YS, El-Maraghy NN, Ahmed AE, Nofal S, Abdel-Mottaleb Y, Badary OA (2018) Thymoquinone alleviates the experimentally induced Alzheimer\u2019s disease inflammation by modulation of TLRs signaling. Hum Exp Toxicol 37:1092\u20131104","journal-title":"Hum Exp Toxicol"},{"key":"1870_CR3","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1016\/j.jsps.2023.01.005","volume":"31","author":"A Alanazi","year":"2023","unstructured":"Alanazi A, Nagi MN, Alhareth DY, Al-Hamamah MA, Mahmoud MA, Ahmad SF, Ansari MA, Nadeem A, Bakheet SA, Harisa GI, Attia SM (2023) Crosstalk of TNF-\u03b1, IFN-\u03b3, NF-kB, STAT1 and redox signaling in lipopolysaccharide\/d-galactosamine\/dimethylsulfoxide-induced fulminant hepatic failure in mice. Saudi Pharm J 31:370\u2013381","journal-title":"Saudi Pharm J"},{"key":"1870_CR4","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1002\/hipo.20806","volume":"21","author":"AM Aleisa","year":"2011","unstructured":"Aleisa AM, Helal G, Alhaider IA, Alzoubi KH, Srivareerat M, Tran TT, Al-Rejaie SS, Alkadhi KA (2011) Acute nicotine treatment prevents REM sleep deprivation-induced learning and memory impairment in rat. Hippocampus 21:899\u2013909","journal-title":"Hippocampus"},{"key":"1870_CR5","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1093\/sleep\/33.4.437","volume":"33","author":"IA Alhaider","year":"2010","unstructured":"Alhaider IA, Aleisa AM, Tran TT, Alzoubi KH, Alkadhi KA (2010) Chronic caffeine treatment prevents sleep deprivation-induced impairment of cognitive function and synaptic plasticity. Sleep 33:437\u2013444","journal-title":"Sleep"},{"key":"1870_CR6","doi-asserted-by":"publisher","unstructured":"AlharethDY, Alanazi A, Alanazi WA, Ansari MA, Nagi MN, Ahmad SF, Attia MSM, Nadeem A, Bakheet SA, Attia SM (2023) Carfilzomib mitigates lipopolysaccharide\/D-galactosamine\/dimethylsulfoxide-induced acute liver failure in mice. Biomedicines 11(11):3098. https:\/\/doi.org\/10.3390\/biomedicines11113098","DOI":"10.3390\/biomedicines11113098"},{"key":"1870_CR7","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1093\/mutage\/get032","volume":"28","author":"SM Attia","year":"2013","unstructured":"Attia SM, Harisa GI, Hassan MH, Bakheet SA (2013) Beryllium chloride-induced oxidative DNA damage and alteration in the expression patterns of DNA repair-related genes. Mutagenesis 28:555\u2013559","journal-title":"Mutagenesis"},{"key":"1870_CR8","first-page":"100044","volume":"5","author":"L Blaikie","year":"2022","unstructured":"Blaikie L, Kay G, Maciel P, Kong Thoo Lin P (2022) Experimental modelling of Alzheimer\u2019s disease for therapeutic screening. Eur J Med Chem Rep 5:100044","journal-title":"Eur J Med Chem Rep"},{"key":"1870_CR9","doi-asserted-by":"publisher","first-page":"799","DOI":"10.3233\/JAD-210256","volume":"83","author":"HY Cai","year":"2021","unstructured":"Cai HY, Yang D, Qiao J, Yang JT, Wang ZJ, Wu MN, Qi JS, H\u00f6lscher C (2021) A GLP-1\/GIP Dual Receptor Agonist DA4-JC Effectively Attenuates Cognitive Impairment and Pathology in the APP\/PS1\/Tau Model of Alzheimer\u2019s Disease. J Alzheimers Dis 83:799\u2013818","journal-title":"J Alzheimers Dis"},{"key":"1870_CR10","doi-asserted-by":"publisher","first-page":"1602","DOI":"10.1016\/j.biopha.2018.04.152","volume":"103","author":"SM Chiroma","year":"2018","unstructured":"Chiroma SM, Mohd Moklas MA, Mat Taib CN, Baharuldin MTH, Amon Z (2018) d-galactose and aluminium chloride induced rat model with cognitive impairments. Biomed Pharmacother 103:1602\u20131608","journal-title":"Biomed Pharmacother"},{"key":"1870_CR11","doi-asserted-by":"publisher","first-page":"1397","DOI":"10.1016\/j.neubiorev.2011.03.001","volume":"35","author":"LA Craig","year":"2011","unstructured":"Craig LA, Hong NS, McDonald RJ (2011) Revisiting the cholinergic hypothesis in the development of Alzheimer\u2019s disease. Neurosci Biobehav Rev 35:1397\u20131409","journal-title":"Neurosci Biobehav Rev"},{"key":"1870_CR12","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1111\/dom.14831","volume":"25","author":"C De Block","year":"2023","unstructured":"De Block C, Bailey C, Wysham C, Hemmingway A, Allen SE, Peleshok J (2023) Tirzepatide for the treatment of adults with type 2 diabetes: An endocrine perspective. Diabetes Obes Metab 25:3\u201317","journal-title":"Diabetes Obes Metab"},{"key":"1870_CR13","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/j.pharmthera.2019.03.005","volume":"199","author":"A Eid","year":"2019","unstructured":"Eid A, Mhatre I, Richardson JR (2019) Gene-environment interactions in Alzheimer\u2019s disease: A potential path to precision medicine. Pharmacol Ther 199:173\u2013187","journal-title":"Pharmacol Ther"},{"key":"1870_CR14","doi-asserted-by":"publisher","first-page":"101","DOI":"10.2174\/1570159X13666150716165726","volume":"14","author":"TH Ferreira-Vieira","year":"2016","unstructured":"Ferreira-Vieira TH, Guimaraes IM, Silva FR, Ribeiro FM (2016) Alzheimer\u2019s disease: Targeting the Cholinergic System. Curr Neuropharmacol 14:101\u2013115","journal-title":"Curr Neuropharmacol"},{"key":"1870_CR15","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1186\/s12967-024-04927-z","volume":"22","author":"RA Fontanella","year":"2024","unstructured":"Fontanella RA, Ghosh P, Pesapane A, Taktaz F, Puocci A, Franzese M, Feliciano MF, Tortorella G, Scisciola L, Sommella E, Ambrosino C, Paolisso G, Barbieri M (2024) Tirzepatide prevents neurodegeneration through multiple molecular pathways. J Transl Med 22:114","journal-title":"J Transl Med"},{"key":"1870_CR16","doi-asserted-by":"publisher","first-page":"102019","DOI":"10.1016\/j.molmet.2024.102019","volume":"89","author":"L Forny Germano","year":"2024","unstructured":"Forny Germano L, Koehler JA, Baggio LL, Cui F, Wong CK, Rittig N, Cao X, Matthews D, Drucker DJ (2024) The GLP-1 medicines semaglutide and tirzepatide do not alter disease-related pathology, behaviour or cognitive function in 5XFAD and APP\/PS1 mice. Mol Metab 89:102019","journal-title":"Mol Metab"},{"key":"1870_CR17","doi-asserted-by":"publisher","first-page":"170224","DOI":"10.1016\/j.peptides.2019.170224","volume":"125","author":"MBN Gabe","year":"2020","unstructured":"Gabe MBN, van der Velden WJC, Smit FX, Gasbjerg LS, Rosenkilde MM (2020) Molecular interactions of full-length and truncated GIP peptides with the GIP receptor - A comprehensive review. Peptides 125:170224","journal-title":"Peptides"},{"key":"1870_CR18","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/s40035-022-00279-0","volume":"11","author":"L Gao","year":"2022","unstructured":"Gao L, Zhang Y, Sterling K, Song W (2022) Brain-derived neurotrophic factor in Alzheimer\u2019s disease and its pharmaceutical potential. Transl Neurodegener 11:4","journal-title":"Transl Neurodegener"},{"key":"1870_CR19","doi-asserted-by":"publisher","first-page":"17490","DOI":"10.1038\/s41598-017-17718-y","volume":"7","author":"M Gejl","year":"2017","unstructured":"Gejl M, Brock B, Egefjord L, Vang K, Rungby J, Gjedde A (2017) Blood-Brain Glucose Transfer in Alzheimer\u2019s disease: Effect of GLP-1 Analog Treatment. Sci Rep 7:17490","journal-title":"Sci Rep"},{"key":"1870_CR20","doi-asserted-by":"publisher","first-page":"4872","DOI":"10.7150\/thno.86831","volume":"13","author":"P Ghosh","year":"2023","unstructured":"Ghosh P, Fontanella RA, Scisciola L, Pesapane A, Taktaz F, Franzese M, Puocci A, Ceriello A, Prattichizzo F, Rizzo MR, Paolisso G, Barbieri M (2023) Targeting redox imbalance in neurodegeneration: characterizing the role of GLP-1 receptor agonists. Theranostics 13:4872\u20134884","journal-title":"Theranostics"},{"key":"1870_CR21","doi-asserted-by":"publisher","first-page":"1146960","DOI":"10.3389\/fphar.2023.1146960","volume":"14","author":"X Guo","year":"2023","unstructured":"Guo X, Lei M, Zhao J, Wu M, Ren Z, Yang X, Ouyang C, Liu X, Liu C, Chen Q (2023) Tirzepatide ameliorates spatial learning and memory impairment through modulation of aberrant insulin resistance and inflammation response in diabetic rats. Front Pharmacol 14:1146960","journal-title":"Front Pharmacol"},{"key":"1870_CR22","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/0926-6410(96)00004-3","volume":"3","author":"H Hodges","year":"1996","unstructured":"Hodges H (1996) Maze procedures: the radial-arm and water maze compared. Brain Res Cogn Brain Res 3:167\u2013181","journal-title":"Brain Res Cogn Brain Res"},{"key":"1870_CR23","doi-asserted-by":"publisher","unstructured":"HuangJ, Huang N, Cui D, Shi J, Qiu Y (2023) Clinical antidiabetic medication used in Alzheimer\u2019s disease: From basic discovery to therapeutics development. Front Aging Neurosci 15:1122300. https:\/\/doi.org\/10.3389\/fnagi.2023.1122300","DOI":"10.3389\/fnagi.2023.1122300"},{"key":"1870_CR24","doi-asserted-by":"crossref","unstructured":"Ibrahim AM, Chauhan L, Bhardwaj A, Sharma A, Fayaz F, Kumar B, Alhashmi M, AlHajri N, Alam MS, Pottoo FH (2022) Brain-derived neurotropic factor in neurodegenerative disorders. Biomedicines 10.","DOI":"10.3390\/biomedicines10051143"},{"key":"1870_CR25","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1515\/revneuro-2015-0021","volume":"27","author":"C Ji","year":"2016","unstructured":"Ji C, Xue GF, Li G, Li D, H\u00f6lscher C (2016) Neuroprotective effects of glucose-dependent insulinotropic polypeptide in Alzheimer\u2019s disease. Rev Neurosci 27:61\u201370","journal-title":"Rev Neurosci"},{"key":"1870_CR26","first-page":"1","volume-title":"Neuroscience in the 21st Century","author":"RH Kennedy","year":"2016","unstructured":"Kennedy RH, Silver R (2016) Neuroimmune Signaling: Cytokines and the CNS. In: Pfaff DW, Volkow ND (eds) Neuroscience in the 21st Century. Springer New York, New York, NY, pp 1\u201341"},{"key":"1870_CR27","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1038\/s41572-021-00269-y","volume":"7","author":"DS Knopman","year":"2021","unstructured":"Knopman DS, Amieva H, Petersen RC, Ch\u00e9telat G, Holtzman DM, Hyman BT, Nixon RA, Jones DT (2021) Alzheimer disease. Nat Reviews Disease Primers 7:33","journal-title":"Nat Reviews Disease Primers"},{"key":"1870_CR28","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1006\/meth.2001.1262","volume":"25","author":"KJ Livak","year":"2001","unstructured":"Livak KJ, Schmittgen TD (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 25:402\u2013408","journal-title":"Methods"},{"key":"1870_CR29","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1016\/j.cell.2019.09.001","volume":"179","author":"JM Long","year":"2019","unstructured":"Long JM, Holtzman DM (2019) Alzheimer Disease: An Update on Pathobiology and Treatment Strategies. Cell 179:312\u2013339","journal-title":"Cell"},{"key":"1870_CR30","doi-asserted-by":"publisher","unstructured":"MahdiO, Chiroma SM, Hidayat Baharuldin MT, Mohd Nor NH, Taib M, Jagadeesan CN, Devi S, Moklas SM, M.A (2021) WIN55,212-2 attenuates cognitive impairments in AlCl(3)\u2009+\u2009d-galactose-induced alzheimer\u2019s disease rats by enhancing neurogenesis and reversing oxidative stress. Biomedicines 9(9):1270. https:\/\/doi.org\/10.3390\/biomedicines9091270","DOI":"10.3390\/biomedicines9091270"},{"key":"1870_CR31","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1515\/revneuro-2019-0089","volume":"31","author":"A Majdi","year":"2020","unstructured":"Majdi A, Sadigh-Eteghad S, Aghsan SR, Farajdokht F, Vatandoust SM, Namvaran A, Mahmoudi J (2020) Amyloid-\u03b2, tau, and the cholinergic system in Alzheimer\u2019s disease: seeking direction in a tangle of clues. Rev Neurosci 31:391\u2013413","journal-title":"Rev Neurosci"},{"key":"1870_CR32","doi-asserted-by":"publisher","first-page":"153331752095304","DOI":"10.1177\/1533317520953041","volume":"35","author":"M Maskery","year":"2020","unstructured":"Maskery M, Goulding EM, Gengler S, Melchiorsen JU, Rosenkilde MM, H\u00f6lscher C (2020) The Dual GLP-1\/GIP Receptor Agonist DA4-JC Shows Superior Protective Properties Compared to the GLP-1 Analogue Liraglutide in the APP\/PS1 Mouse Model of Alzheimer\u2019s Disease. Am J Alzheimers Dis Other Demen 35:1533317520953041","journal-title":"Am J Alzheimers Dis Other Demen"},{"key":"1870_CR33","first-page":"31","volume":"12","author":"S Mehan","year":"2022","unstructured":"Mehan S, Bhalla S, Siddiqui EM, Sharma N, Shandilya A, Khan A (2022) Potential Roles of Glucagon-Like Peptide-1 and Its Analogues in Dementia Targeting Impaired Insulin Secretion and Neurodegeneration. Degener Neurol Neuromuscul Dis 12:31\u201359","journal-title":"Degener Neurol Neuromuscul Dis"},{"key":"1870_CR34","doi-asserted-by":"publisher","first-page":"1148209","DOI":"10.3389\/fimmu.2023.1148209","volume":"14","author":"SF Mehdi","year":"2023","unstructured":"Mehdi SF, Pusapati S, Anwar MS, Lohana D, Kumar P, Nandula SA, Nawaz FK, Tracey K, Yang H, LeRoith D, Brownstein MJ, Roth J (2023) Glucagon-like peptide-1: a multi-faceted anti-inflammatory agent. Front Immunol 14:1148209","journal-title":"Front Immunol"},{"key":"1870_CR35","doi-asserted-by":"publisher","unstructured":"MichailidisM, Moraitou D, Tata DA, Kalinderi K, Papamitsou T, Papaliagkas V (2022) Alzheimer\u2019s disease as type 3 diabetes: common pathophysiological mechanisms between Alzheimer\u2019s disease and type 2 diabetes. Int J Mol Sci 23(5):2687. https:\/\/doi.org\/10.3390\/ijms23052687","DOI":"10.3390\/ijms23052687"},{"key":"1870_CR36","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1615\/CritRevNeurobiol.v16.i12.50","volume":"16","author":"I Mocchetti","year":"2004","unstructured":"Mocchetti I, Bachis A (2004) Brain-derived neurotrophic factor activation of TrkB protects neurons from HIV-1\/gp120-induced cell death. Crit Rev Neurobiol 16:51\u201357","journal-title":"Crit Rev Neurobiol"},{"key":"1870_CR37","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1038\/297681a0","volume":"297","author":"RG Morris","year":"1982","unstructured":"Morris RG, Garrud P, Rawlins JN, O\u2019Keefe J (1982) Place navigation impaired in rats with hippocampal lesions. Nature 297:681\u2013683","journal-title":"Nature"},{"key":"1870_CR38","doi-asserted-by":"publisher","first-page":"e12268","DOI":"10.1002\/trc2.12268","volume":"8","author":"CH N\u00f8rgaard","year":"2022","unstructured":"N\u00f8rgaard CH, Friedrich S, Hansen CT, Gerds T, Ballard C, M\u00f8ller DV, Knudsen LB, Kvist K, Zinman B, Holm E, Torp-Pedersen C, M\u00f8rch LS (2022) Treatment with glucagon-like peptide-1 receptor agonists and incidence of dementia: Data from pooled double-blind randomized controlled trials and nationwide disease and prescription registers. Alzheimers Dement (N Y) 8:e12268","journal-title":"Alzheimers Dement (N Y)"},{"key":"1870_CR39","doi-asserted-by":"publisher","first-page":"848","DOI":"10.3390\/molecules30040848","volume":"30","author":"T Numakawa","year":"2025","unstructured":"Numakawa T, Kajihara R (2025) The Role of Brain-Derived Neurotrophic Factor as an Essential Mediator in Neuronal Functions and the Therapeutic Potential of Its Mimetics for Neuroprotection in Neurologic and Psychiatric Disorders. Molecules 30:848","journal-title":"Molecules"},{"key":"1870_CR40","doi-asserted-by":"publisher","first-page":"Itc33","DOI":"10.7326\/AITC201909030","volume":"171","author":"ES Oh","year":"2019","unstructured":"Oh ES, Rabins PV (2019) Dement Ann Intern Med 171:Itc33\u2013itc48","journal-title":"Dement Ann Intern Med"},{"key":"1870_CR41","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1111\/psyg.12944","volume":"23","author":"A Rahman","year":"2023","unstructured":"Rahman A, Hossen MA, Chowdhury MFI, Bari S, Tamanna N, Sultana SS, Haque SN, Al Masud A, Saif-Ur-Rahman KM (2023) Aducanumab for the treatment of Alzheimer\u2019s disease: a systematic review. Psychogeriatrics 23:512\u2013522","journal-title":"Psychogeriatrics"},{"key":"1870_CR42","doi-asserted-by":"publisher","first-page":"970925","DOI":"10.3389\/fnins.2022.970925","volume":"16","author":"N Reich","year":"2022","unstructured":"Reich N, H\u00f6lscher C (2022) The neuroprotective effects of glucagon-like peptide 1 in Alzheimer\u2019s and Parkinson\u2019s disease: An in-depth review. Front Neurosci 16:970925","journal-title":"Front Neurosci"},{"key":"1870_CR43","doi-asserted-by":"publisher","first-page":"2292461","DOI":"10.1080\/21688370.2023.2292461","volume":"12","author":"EM Rhea","year":"2024","unstructured":"Rhea EM, Babin A, Thomas P, Omer M, Weaver R, Hansen K, Banks WA, Talbot K (2024) Brain uptake pharmacokinetics of albiglutide, dulaglutide, tirzepatide, and DA5-CH in the search for new treatments of Alzheimer\u2019s and Parkinson\u2019s diseases. Tissue Barriers 12:2292461","journal-title":"Tissue Barriers"},{"key":"1870_CR44","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1038\/s41591-022-01707-4","volume":"28","author":"N Sattar","year":"2022","unstructured":"Sattar N, McGuire DK, Pavo I, Weerakkody GJ, Nishiyama H, Wiese RJ, Zoungas S (2022) Tirzepatide cardiovascular event risk assessment: a pre-specified meta-analysis. Nat Med 28:591\u2013598","journal-title":"Nat Med"},{"key":"1870_CR45","doi-asserted-by":"publisher","first-page":"3103","DOI":"10.1007\/s11064-021-03418-7","volume":"46","author":"VK Sharma","year":"2021","unstructured":"Sharma VK, Singh TG, Singh S, Garg N, Dhiman S (2021) Apoptotic Pathways and Alzheimer\u2019s Disease: Probing Therapeutic Potential. Neurochem Res 46:3103\u20133122","journal-title":"Neurochem Res"},{"key":"1870_CR46","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.exger.2017.10.029","volume":"101","author":"T Shwe","year":"2018","unstructured":"Shwe T, Pratchayasakul W, Chattipakorn N, Chattipakorn SC (2018) Role of D-galactose-induced brain aging and its potential used for therapeutic interventions. Exp Gerontol 101:13\u201336","journal-title":"Exp Gerontol"},{"key":"1870_CR47","first-page":"1","volume":"5","author":"AV Skalny","year":"2021","unstructured":"Skalny AV, Aschner M, Jiang Y, Gluhcheva YG, Tizabi Y, Lobinski R, Tinkov AA (2021) Molecular mechanisms of aluminum neurotoxicity: Update on adverse effects and therapeutic strategies. Adv Neurotoxicol 5:1\u201334","journal-title":"Adv Neurotoxicol"},{"key":"1870_CR48","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1037\/0033-2909.83.3.482","volume":"83","author":"RN Walsh","year":"1976","unstructured":"Walsh RN, Cummins RA (1976) The Open-Field Test: a critical review. Psychol Bull 83:482\u2013504","journal-title":"Psychol Bull"},{"key":"1870_CR49","first-page":"136","volume":"3","author":"WY Wang","year":"2015","unstructured":"Wang WY, Tan MS, Yu JT, Tan L (2015) Role of pro-inflammatory cytokines released from microglia in Alzheimer\u2019s disease. Ann Transl Med 3:136","journal-title":"Ann Transl Med"},{"key":"1870_CR50","doi-asserted-by":"publisher","first-page":"117","DOI":"10.2147\/JN.S125567","volume":"5","author":"Y Wang","year":"2017","unstructured":"Wang Y, Li J, Wang Y, Xu C, Hua L, Yang X, Geng S, Wang S, Wang Z, Yin H (2017) Curcumin reduces hippocampal neuron apoptosis and JNK-3 phosphorylation in rats with A\u03b2-induced Alzheimer\u2019s disease: protecting spatial learning and memory. J Neurorestoratology 5:117\u2013123","journal-title":"J Neurorestoratology"},{"key":"1870_CR51","first-page":"192","volume":"2","author":"Q-Q Xu","year":"2023","unstructured":"Xu Q-Q, Yang W, Zhong M, Lin Z-X, Gray NE, Xian Y-F (2023) Animal models of Alzheimer\u2019s disease: preclinical insights and challenges. Acta Materia Med 2:192\u2013215","journal-title":"Acta Materia Med"},{"key":"1870_CR52","doi-asserted-by":"publisher","first-page":"171271","DOI":"10.1016\/j.peptides.2024.171271","volume":"179","author":"S Yang","year":"2024","unstructured":"Yang S, Zhao X, Zhang Y, Tang Q, Li Y, Du Y, yu P (2024) Tirzepatide shows neuroprotective effects via regulating brain glucose metabolism in APP\/PS1 mice. Peptides 179:171271","journal-title":"Peptides"},{"key":"1870_CR53","doi-asserted-by":"publisher","first-page":"117957352090739","DOI":"10.1177\/1179573520907397","volume":"12","author":"KG Yiannopoulou","year":"2020","unstructured":"Yiannopoulou KG, Papageorgiou SG (2020) Current and Future Treatments in Alzheimer Disease: An Update. J Cent Nerv Syst Dis 12:1179573520907397","journal-title":"J Cent Nerv Syst Dis"},{"key":"1870_CR54","doi-asserted-by":"publisher","first-page":"1721727X2210953","DOI":"10.1177\/1721727X221095383","volume":"20","author":"J Zhao","year":"2022","unstructured":"Zhao J, Zhao D, Wang J, Luo X, Guo R (2022) Inflammation\u2014Cause or consequence of late onset Alzheimer\u2019s disease or both? A review of the evidence. Eur J Inflamm 20:1721727X221095383","journal-title":"Eur J Inflamm"}],"container-title":["Metabolic Brain Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11011-026-01870-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11011-026-01870-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11011-026-01870-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T07:03:08Z","timestamp":1781852588000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11011-026-01870-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,19]]},"references-count":54,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1870"],"URL":"https:\/\/doi.org\/10.1007\/s11011-026-01870-4","relation":{},"ISSN":["1573-7365"],"issn-type":[{"value":"1573-7365","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,19]]},"assertion":[{"value":"2 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"100"}}